Relationship between autonomic dysfunction, insulin resistance and hypertension, in diabetes

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 15, Issue 6, 2005, Pages 441-449

  Frontoni, Simona ^a   Bracaglia, Daniela ^a   Gigli, Fabrizio ^a  

^a UNIVERSITY OF ROME TOR VERGATA   (Italy)

Author keywords

Autonomic balance; Hypertension; Insulin resistance

Indexed keywords

AUTONOMIC NEUROPATHY; DIABETES MELLITUS; HUMAN; HYPERTENSION; INSULIN RESISTANCE; PATHOPHYSIOLOGY; REVIEW;

AUTONOMIC NERVOUS SYSTEM DISEASES; DIABETES MELLITUS; HUMANS; HYPERTENSION; INSULIN RESISTANCE;

EID: 33646183366     PISSN: 09394753     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.numecd.2005.06.010     Document Type: Short Survey

References (57)

1. Teuscher A, Egger M, Herman JB. Blood pressure in clinical diabetic patients and a control population. Arch Intern Med 1989;149:1942-5.
2. Major SG. Blood pressure in diabetes mellitus: a statistical study. Arch Intern Med 1929;44:797-812.
3. Ferrannini E, Buzzigoli G, Bonadonna R, Giorico MA, Oleggini M, Graziadei L, et al. Insulin resistance in essential hypertension. N Engl J Med 1987;317:350-7.
4. Rossetti L, Frontoni S. Mechanisms of hypertension in diabetes mellitus. In: Draznin B, Eckel RH, editors. Diabetes and atherosclerosis-molecular basis and clinical aspects; 1993. p. 277-89.
5. Bonora E, Zavaroni I, Alpi O, Pezzarossa A, Bruschi F, Dall'Aglio E, et al. Relationship between blood pressure and plasma insulin in non-obese and obese non-diabetic subjects. Diabetologia 1987;30:719-23.
6. Mondon CE, Reaven GM. Evidence of abnormalities of insulin metabolism in rats with spontaneous hypertension. Metab Clin Exp 1988;37:303-5.
7. Buchan TA, Sipos GF, Madrilejo N, Liu C, Campese VM. Hypertension without peripheral insulin resistance in spontaneously hypertensive rats. Am J Physiol 1992;262(Endocrinol Metab 25):E149.
8. Frontoni S, Ohman L, Haywood JR, DeFronzo RA, Rossetti L. In vivo insulin action in genetic models of hypertension. Am J Physiol 1992;262(Endocrinol Metab 25):E191-6.
9. Tsutsu N, Takata Y, Nunoi K, Kikuchi M, Takishita S, Sadoshima S, et al. Glucose tolerance and insulin secretion in conscious and unstrained normotensive and spontaneously hypertensive rats. Metab Clin Exp 1989;38:63-6.
10. Frontoni S, Ohman L, Haywood JR, Rossetti L. Increased insulin sensitivity in the high-sodium, one-kidney, one figure-8 hypertensive rats. Hypertension August 1992;20(2):1-6.
11. Bravo EL. Metabolic factors and the sympathetic nervous system. Am J Hypertens 1989;2:339S-44S.
12. Deibert DC, DeFronzo RA. Epinephrine-induced insulin resistance in man. J Clin Invest 1980;65:717-21.
13. Porte Jr D. Sympathetic regulation of insulin secretion. Arch Intern Med 1969;123:252-60.
14. Rizza RA, Cryer PE, Haymond MW, Gerich JE. Adrenergic mechanisms for the effects of epinephrine on glucose production and clearance in man. J Clin Invest 1980;65:682-9.
15. Werther GA, Joffe S, Artal R, Sperling MA. Physiological insulin action is opposed by β-adrenergic mechanisms in dogs. Am J Physiol 1988;255:E33-40.
16. Young DA, Wallber-Henriksson H, Cranshaw J, Chen M, Holloszy JO. Effect of catecholamines on glucose uptake and glycogenolysis in rat skeletal muscle. Am J Physiol 1985;248:C406-9.
17. Chiasson JL, Shikama H, Chu DTW, Exton JH. Inhibitory effect of epinephrine on insulin-stimulated glucose uptake by rat skeletal muscle. J Clin Invest 1981;68:706-13.
18. Lupien JR, Hirshman MF, Horton ES. Effects of norepinephrine infusion on in vivo insulin sensitivity and responsiveness. Am J Physiol 1990;259:E210-5.
19. Hall JE, Coleman TG, Mizelle HL, Smith Jr MJ. Chronic hyperinsulinemia and blood pressure regulation. Am J Physiol 1990;258:F722-31.
20. Berne C, Fagius J, Pollare T, Hjelmdahl P. The sympathetic response to euglycemic hyperinsulinemia: the evidence from microelectrode nerve recordings in healthy subjects. Diabetologia 1992;35:873-9.
21. Anderson EA, Balon TW, Hoffmann RP, Sinkey CA, Mark AL. Insulin increases sympathetic activity but not blood pressure in borderline hypertensive humans. Hypertension 1992;19:621-7.
22. Anderson EA, Hoffmann RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 1991;87:2246-52.
23. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-94.
24. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Eur Heart J 1996;17:354-81.
25. Landsberg L. Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens 2001;19:523-8.
26. Landsberg L, Troisi R, Parker DR, Young JB, Weiss ST. Obesity, blood pressure and the sympathetic nervous system. Ann Epidemiol 1991;1:295-303.
27. Troisi RJ, Weiss ST, Parker DR, Sparrow D, Young JB, Landsberg L. Relation of obesity and diet to sympathetic nervous system activity. Hypertension 1991;17:669-77.
28. Muscelli E, Emdin M, Natali A, Pratali L, Camastra S, Gastaldelli A, et al. Autonomic and haemodynamic responses to insulin in lean and obese humans. J Clin Endocrinol Metab 1998;83(6):2084-90.
29. Reaven GM, Lithell H, Landsberg L. Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 1996;6:374-81.
30. Foersblom CM, Eriksson JG, Ekstrand AV, Teppo A-M, Taskinen M-R, Groop LC. Insulin resistance and abnormal albumin excretion in non-diabetic first-degree relatives of patients with NIDDM. Diabetologia 1995;38:363-9.
31. Migdalis IN, Zachariadis D, Kalogeropoulou K, Nounopoulos C, Bouloukos A, Samartzis M. Metabolic abnormalities in offspring of NIDDM patients with a family history of diabetes mellitus. Diabet Med 1996;13:434-40.
32. Groop L, Forsblom C, Lehtovirta M, Tuomi T, Karanko S, Nissen M, et al. Metabolic consequences of a family history of NIDDM (The Botnia Study). Diabetes 1996;45:1585-93.
33. Perseghin G, Ghosh S, Gerow K, Shulman GI. Metabolic defects in lean nondiabetic offspring of NIDDM parents. Diabetes 1997;46:1001-9.
34. Laitinen T, Vauhkonen IK, Niskanen LK, Hartikainen JE, Lansimies EA, Uusitupa MI, et al. Power spectral analysis of heart rate variability during hyperinsulinemia in non-diabetic offspring of Type 2 diabetic patients. Diabetes 1999;48:1295-9.
35. Frontoni S, Bracaglia D, Baroni A, Pellegrini F, Perna M, Cicconetti E, et al. Early autonomic dysfunction in glucose-tolerant but insulin-resistant offspring of type 2 diabetic patients. Hypertension 2003;41:1223-7.
36. Julius S, Gudbrandsson T, Jamerson K, Shahab ST, Andersson O. Hypothesis. The haemodynamic link between insulin resistance and hypertension. J Hypertens 1991;9:983-6.
37. Julius S, Gudbrandsson T, Jamerson K, Andersson O. The interconnection between sympathetics, microcirculation, and insulin resistance in hypertension. Blood Pressure 1992;1:9-19.
38. Pollare T, Lithell H, Morlin C, Prantare H, Hvarfner A, Ljunghall S. Metabolic effects of diltiazem and atenolol. Results from a randomised, double-blind study with parallel groups. J Hypertens 1989;7:551-9.
39. Pollare S, Lithell H, Selinus I, Berne C. Application of prazosin is associated with an increase of insulin sensitivity in obese patients with hypertension. Diabetologia 1988;31:415-20.
40. Jamerson K, Julius S, Gudbrandsson T, Andersson O, Brant DO. Reflex sympathetic activation induces acute insulin resistance in the human forearm. Hypertension 1993;21:618-23.
41. Krotkiewski M, Bylund-Fallenius AC, Holm J, Bjorntorp P, Grimby G, Mandroukas K, et al. Relationship between muscle morphology and metabolism in obese women: the effects of long-term physical training. Eur J Clin Invest 1983;13:5-12.
42. Johlin-Danfelt A, Frisk-Holmberg F, Karlsson J, Tesch P. Central and peripheral circulation in relation to muscle-fiber composition in normo- and hypertensive men. Clin Sci 1979;56:335-40.
43. Laasko M, Edelman SV, Brechtel G, Baron AD. Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. J Clin Invest 1990;85:1844-52.
44. Baron A. Haemodynamic actions of insulin. Am J Physiol 1994;267:E187-202.
45. Baron AD, Brechtel-Hook G, Johnson A, Hardin D. Skeletal muscle blood flow. A possible link between insulin resistance and blood pressure. Hypertension 1993;21 (2):129-35.
46. Liang C, Doherty JU, Faillace R, Maekawa K, Arnold S, Gavras H, et al. Insulin infusion in conscious dogs, effects on systemic and coronary hemodynamics, regional blood flows; plasma catecholamines. J Clin Invest 1982;69:1321-6.
47. Laasko M, Edelman SV, Brechtel G, Baron AD. Impaired insulin-mediated skeletal muscle blood flow in patients with NIDDM. Diabetes 1992;41(9):1076-83.
48. Steinberg HO, Baron AD. Insulin-dependent diabetes mellitus and nitrovasodilation. Important and complex interactions. Circulation 1997;95(3):560-1.
49. 18F)fluoro- deoxy-glucose and positron emission tomography. J Clin Invest 1996;97:1741-7.
50. Natali AR, Bonadonna D, Santoro D, Galvan AQ, Baldi S, Frascerra S, et al. Insulin resistance and vasodilation in essential hypertension. Studies with adenosine. J Clin Invest 1994;94:1570-6.
51. Buchanan TA, Thawani H, Kades W, Modrall JG, Weaver FA, Laurel C, et al. Angiotensin II increases glucose utilization during acute hyperinsulinemia via a haemodynamic mechanism. J Clin Invest 1993;92:720-6.
52. Laine H, Yki-Jarvinen H, Kirvela O, Tolvanen T, Raitakari M, Solin O, et al. Insulin resistance of glucose uptake in skeletal muscle cannot be ameliorated by enhancing endothelium-dependent blood flow in obesity. J Clin Invest 1998;101(5):1156-62.
53. Renkin EM. Effects of blood flow on diffusion kinetics in isolated, perfused hindlimbs of cats. Am J Physiol 1955;183:125-36.
54. Bonadonna RC, Saccomani MP, Del Prato S, Bonora E, DeFronzo RA, Corbelli C. Role of tissue-specific blood flow and tissue recruitment in insulin-mediated glucose uptake of human skeletal muscle. Circulation 1998;98(3):234-41.
55. Rattigan S, Clark MG, Barrett EJ. Hemodynamic actions of insulin in rat skeletal muscle: evidence for capillary recruitment. Diabetes 1997;46:1381-8.
56. Clerk LH, Vincent MA, Linder JR, Clark MG, Rattigan S, Barrett EJ. The vasodilatory cations of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake. Diabet Met Res Rev 2004;20:3-12.
57. Julius S, Valentini M, Palatini P. Overweight and hypertension. A 2-way street? Hypertension 2000;35:807-13.